| The role of the neuroendocrine and immune systems in the pathogenesis of depression E Ogłodek, A Szota, M Just, D Moś, A Araszkiewicz Pharmacological Reports 66, 776-781, 2014 | 100 | 2014 |
| Melatonin and neurotrophins NT-3, BDNF, NGF in patients with varying levels of depression severity EA Ogłodek, MJ Just, AR Szromek, A Araszkiewicz Pharmacological Reports 68, 945-951, 2016 | 85 | 2016 |
| Comparison of chemokines (CCL-5 and SDF-1), chemokine receptors (CCR-5 and CXCR-4) and IL-6 levels in patients with different severities of depression EA Ogłodek, A Szota, MJ Just, D Moś, A Araszkiewicz Pharmacological Reports 66 (5), 920-926, 2014 | 59 | 2014 |
| The MCP-1, CCL-5 and SDF-1 chemokines as pro-inflammatory markers in generalized anxiety disorder and personality disorders EA Ogłodek, AM Szota, MJ Just, DM Moś, A Araszkiewicz Pharmacological Reports 67, 85-89, 2015 | 49 | 2015 |
| The association between inflammatory markers (iNOS, HO-1, IL-33, MIP-1β) and depression with and without posttraumatic stress disorder EA Ogłodek, MJ Just Pharmacological Reports 70, 1065-1072, 2018 | 41 | 2018 |
| The impact of antipsychotics as a risk factor for thromboembolism EA Ogłodek, MJ Just, AD Grzesińska, A Araszkiewicz, AR Szromek Pharmacological Reports 70 (3), 533-539, 2018 | 30 | 2018 |
| The role of PON-1, GR, IL-18, and OxLDL in depression with and without posttraumatic stress disorder EA Ogłodek Pharmacological Reports 69, 837-845, 2017 | 28 | 2017 |
| Serum concentrations of chemokines (CCL-5 and CXCL-12), chemokine receptors (CCR-5 and CXCR-4), and IL-6 in patients with posttraumatic stress disorder and avoidant personality … EA Ogłodek, AM Szota, DM Moś, A Araszkiewicz, AR Szromek Pharmacological Reports 67 (6), 1251-1258, 2015 | 28 | 2015 |
| Fever development in neuroleptic malignant syndrome during treatment with olanzapine and clozapine A Szota, E Ogłodek, A Araszkiewicz Pharmacological Reports 65 (2), 279-287, 2013 | 28 | 2013 |
| Changes in the concentrations of inflammatory and oxidative status biomediators (MIP-1 α, PMN elastase, MDA, and IL-12) in depressed patients with and without posttraumatic … EA Ogłodek Pharmacological Reports 70, 110-118, 2018 | 27 | 2018 |
| Sense of alexithymia in patients with anxiety disorders comorbid with recurrent urticaria EA Ogłodek, AM Szota, MJ Just, A Araszkiewicz, AR Szromek Neuropsychiatric disease and treatment, 995-1004, 2016 | 26 | 2016 |
| Changes in the Serum Levels of Cytokines: IL-1β, IL-4, IL-8 and IL-10 in Depression with and without Posttraumatic Stress Disorder E Ogłodek Brain Sciences 12 (3), 387, 2022 | 17 | 2022 |
| Assessing the serum concentration levels of NT-4/5, GPX-1, TNF-α, and l-arginine as biomediators of depression severity in first depressive episode patients with and without … EA Ogłodek, MJ Just, AR Szromek, A Araszkiewicz Pharmacological Reports 69 (5), 1049-1058, 2017 | 17 | 2017 |
| Stygmatyzacja osób chorych na łuszczycę E Ogłodek, A Araszkiewicz, W Placek Zdrowie Publiczne 119 (3), 335-337, 2009 | 15 | 2009 |
| A study of chemokines, chemokine receptors and interleukin-6 in patients with panic disorder, personality disorders and their co-morbidity EA Ogłodek, AM Szota, MJ Just, AR Szromek, A Araszkiewicz Pharmacological Reports 68, 756-763, 2016 | 13 | 2016 |
| Changes in the serum concentration levels of serotonin, tryptophan and cortisol among stress-resilient and stress-susceptible individuals after experiencing traumatic stress EA Ogłodek International Journal of Environmental Research and Public Health 19 (24), 16517, 2022 | 12 | 2022 |
| Is water-only fasting safe? E Ogłodek, W Pilis, Prof Global Advances in Health and Medicine 10, 21649561211031178, 2021 | 11 | 2021 |
| Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment E Ogłodek, A Szota, A Araszkiewicz Aust NZJ Psychiatry 47 (10), 972, 2013 | 9 | 2013 |
| Evaluation of ADMA, carbonyl groups, CAT and NKA in depressed patients with and without posttraumatic stress disorder EA Ogłodek Pharmacological Reports 69, 730-737, 2017 | 8 | 2017 |
| Zasady kontaktu terapeutycznego lekarza z pacjentem E Ogłodek, D Moś, A Araszkiewicz Zdrowie Publiczne 119 (3), 331-334, 2009 | 8 | 2009 |
